Sudeep Pharma shareholding pattern

Who owns itSep 2026 quarter

Promoters76.15%no change
Foreign investors (FII)2.93%+1.12 pts
Domestic institutions (DII)14.05%−1.60 pts
of which mutual funds7.43%+1.96 pts
of which insurance companies1.02%
Public6.87%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SUDEEPPHRM₹960.00

Sudeep Pharma Ltd.

· Chemicals
₹ CrorePeersSUDARSCHEMSTYRENIXSHARDACROPREFEXRCFRALLISRAINPRIVISCLMcap ₹10,843 Cr
Holding % of Total Shares
12 Months Ending
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Promoter & Group76.1576.1576.1576.15
FII / FPI1.671.551.812.93
DII17.6018.1115.6514.05
Mutual Funds5.676.195.477.43
Latest: 2026-09-30 · 5 quarters of history · click a row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.